首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1732695篇
  免费   139762篇
  国内免费   2878篇
耳鼻咽喉   23587篇
儿科学   57307篇
妇产科学   49219篇
基础医学   244815篇
口腔科学   54086篇
临床医学   149994篇
内科学   342129篇
皮肤病学   37756篇
神经病学   141119篇
特种医学   68930篇
外国民族医学   498篇
外科学   260869篇
综合类   40818篇
一般理论   604篇
预防医学   137201篇
眼科学   39000篇
药学   129457篇
  2篇
中国医学   3419篇
肿瘤学   94525篇
  2018年   18931篇
  2017年   14782篇
  2016年   15746篇
  2015年   18468篇
  2014年   25524篇
  2013年   37511篇
  2012年   52306篇
  2011年   55000篇
  2010年   31464篇
  2009年   29788篇
  2008年   50747篇
  2007年   53417篇
  2006年   53554篇
  2005年   52455篇
  2004年   51453篇
  2003年   48743篇
  2002年   46132篇
  2001年   78932篇
  2000年   81563篇
  1999年   68982篇
  1998年   17786篇
  1997年   16199篇
  1996年   16145篇
  1995年   16755篇
  1994年   15809篇
  1993年   14925篇
  1992年   57193篇
  1991年   55523篇
  1990年   54200篇
  1989年   52474篇
  1988年   48739篇
  1987年   47964篇
  1986年   45585篇
  1985年   44091篇
  1984年   32900篇
  1983年   28274篇
  1982年   16524篇
  1981年   14753篇
  1979年   31114篇
  1978年   21509篇
  1977年   18053篇
  1976年   16913篇
  1975年   17924篇
  1974年   21843篇
  1973年   21067篇
  1972年   19177篇
  1971年   18045篇
  1970年   16642篇
  1969年   15588篇
  1968年   14277篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Modified-release opioids are often prescribed for the management of moderate to severe acute pain following total hip and knee arthroplasty, despite recommendations against their use due to increasing concerns regarding harm. The primary objective of this multicentre study was to examine the impact of modified-release opioid use on the incidence of opioid-related adverse events compared with immediate-release opioid use, among adult inpatients following total hip or knee arthroplasty. Data for total hip and knee arthroplasty inpatients receiving an opioid analgesic for postoperative analgesia during hospitalisation were collected from electronic medical records of three tertiary metropolitan hospitals in Australia. The primary outcome was the incidence of opioid-related adverse events during hospital admission. Patients who received modified with or without immediate-release opioids were matched to those receiving immediate-release opioids only (1:1) using nearest neighbour propensity score matching with patient and clinical characteristics as covariates. This included total opioid dose received. In the matched cohorts, patients given modified-release opioids (n = 347) experienced a higher incidence of opioid-related adverse events overall, compared with those given immediate-release opioids only (20.5%, 71/347 vs. 12.7%, 44/347; difference in proportions 7.8% [95%CI 2.3–13.3%]). Modified-release opioid use was associated with an increased risk of harm when used for acute pain during hospitalisation after total hip or knee arthroplasty.  相似文献   
3.
Pharmaceutical Chemistry Journal - Metformin hydrochloride is widely used to treat diabetes mellitus. This review presents its physical and chemical properties and discusses methods of analysis...  相似文献   
4.
Khadka  J.  Ratcliffe  J.  Hutchinson  C.  Cleland  J.  Mulhern  B.  Lancsar  E.  Milte  R. 《Quality of life research》2022,31(9):2849-2865
Quality of Life Research - To evaluate the construct (convergent and known group) validity of the Quality-of-Life-Aged Care Consumer (QOL-ACC), an older-person-specific quality-of-life measure...  相似文献   
5.
6.
7.
8.
9.
PurposeTRAPPC9 deficiency is an autosomal recessive disorder mainly associated with intellectual disability (ID), microcephaly, and obesity. Previously, TRAPPC9 deficiency has not been associated with biochemical abnormalities.MethodsExome sequencing was performed in 3 individuals with ID and dysmorphic features. N-Glycosylation analyses were performed in the patients’ blood samples to test for possible congenital disorder of glycosylation (CDG). TRAPPC9 gene, TRAPPC9 protein expression, and N-glycosylation markers were assessed in patient fibroblasts. Complementation with wild-type TRAPPC9 and immunofluorescence studies to assess TRAPPC9 expression and localization were performed. The metabolic consequences of TRAPPC9 deficiency were evaluated using tracer metabolomics.ResultsAll 3 patients carried biallelic missense variants in TRAPPC9 and presented with an N-glycosylation defect in blood, consistent with CDG type I. Extensive investigations in patient fibroblasts corroborated TRAPPC9 deficiency and an N-glycosylation defect. Tracer metabolomics revealed global metabolic changes with several affected glycosylation-related metabolites.ConclusionWe identified 3 TRAPPC9 deficient patients presenting with ID, dysmorphic features, and abnormal glycosylation. On the basis of our findings, we propose that TRAPPC9 deficiency could lead to a CDG (TRAPPC9-CDG). The finding of abnormal glycosylation in these patients is highly relevant for diagnosis, further elucidation of the pathophysiology, and management of the disease.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号